Samodzielny Publiczny Szpital Kliniczny Nr 1 W Lublinie
- Address
- lock Available on a paid plan
Eye Diseases Research
At Samodzielny Publiczny Szpital Kliniczny Nr 1 W Lublinie, clinical trial activity is focused on Eye Diseases, with studies centered on glaucoma, open-angle glaucoma, and ocular hypertension. The research is aimed at understanding how to better protect vision and manage conditions that can lead to progressive eye damage.
- Evaluating new approaches to preserve the visual field in people with progressing open-angle glaucoma
- Assessing the safety and eye pressure–lowering effects of treatments for glaucoma and ocular hypertension
- Improving treatment effectiveness for patients at risk of ongoing vision loss
This small but focused research portfolio reflects a strong interest in testing therapies that may help slow disease progression, support long-term eye health, and improve outcomes for patients with chronic ophthalmic conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Omikron Italia S.r.l.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Samodzielny Publiczny Szpital Kliniczny Nr 1 W Lublinie
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A phase III multicenter, double-blind, randomized, placebo-controlled, parallel-group trial of the efficacy of citicoline eyedrops 2% on visual field preservation in patients with open angle glaucoma | Omikron Italia S.r.l. | Phase III | Recruiting | Nov 2023 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bimatoprost | 1 | Unknown | 2019-11-20 | 2019-11-20 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.